HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

More Consumers Follow Green Instincts In Health-Care Product Choices

This article was originally published in The Rose Sheet

Executive Summary

More mainstream consumers want health-care products to not only be safe and effective, but also “clean,” sustainable and “soulful,” says Hartman Group researcher Greg Prang. A connection between natural and health care sprang from the green movement, which positioned organic as healthier than manmade.

You may also be interested in...



Beauty’s Newest Crop Of “Green” Innovators Comes From Outside Industries

Natural and organic entrepreneurs brought insight and experience from distant industries, and a fresh approach to personal-care marketing, to Natural Products Expo West. New ideas in packaging, ingredient transparency and consumer appeal push “green” into new territory.

BORBA Enters Mass With Aspirations To Be "Synonymous With Innovation"

California-based “beautyceutical” marketer BORBA plans to broaden its customer base with the national debut of a new line exclusively at Walgreens, representing the brand’s first foray into the mass-market channel.

J&J Consumer Sales Slip Even As Recalled Brands, Seasonal Items Reach Stores

J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018118

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel